Results 101 to 110 of about 108,551 (297)
BAK1 (BCL2-antagonist/killer 1) [PDF]
Review on BAK1 (BCL2-antagonist/killer 1), with data on DNA, on the protein encoded, and where the gene is ...
Dewson, G, R Kluck, Kluck, R, G Dewson
core +1 more source
This work identified CPD3a as a potent, stable C‐nucleoside cordycepin derivative. When formulated into microneedle array for topical treatment, it ameliorated psoriasis by rebalancing immunity and enhancing antioxidant defenses. ABSTRACT Psoriasis is a chronic inflammatory disorder characterized by immune dysregulation and epidermal hyperplasia ...
Wenfang Pan +7 more
wiley +1 more source
Post-transcriptional and post-translational regulation of Bcl2
Bcl2 is an important pro-survival protein that has an essential function in normal immunity and whose constitutive expression leads to the development of lymphomas.
Shaun Willimott, Simon D. Wagner
core +1 more source
Small-Molecule Bcl2 BH4 Antagonist for Lung Cancer Therapy [PDF]
SummaryThe BH4 domain of Bcl2 is required for its antiapoptotic function, thus constituting a promising anticancer target. We identified a small-molecule Bcl2-BH4 domain antagonist, BDA-366, that binds BH4 with high affinity and selectivity. BDA-366-Bcl2
Zhou, Jia +15 more
core +1 more source
The CXCL5/CXCR2 axis directly inhibits ferroptosis in ICC cells by activating the NF‐κB/PTGS2 pathway. Meanwhile, the CXCL5/CXCR2 axis recruits N2 TANs, and the activated PTGS2 promotes the secretion of TNF‐α from the recruited N2 TANs via the CCL2/CCL7/CCR2 pathway, thereby activating the NF‐κB/PTGS2 axis and forming a positive feedback loop, which ...
Chanqi Ye +17 more
wiley +1 more source
Role of c-MYC, BCL2, and BCL6 Expression in Pathogenesis of Diffuse Large B-Cell Lymphoma
According to modern concepts based on results of examination of the gene expression profile, there are several subtypes of diffuse large B cell lymphoma (DLBCL): germinal center B cell-like (GCB) and activated B cell-like (ABC) lymphomas.
A. E. Misyurina +4 more
doaj +1 more source
Bcl2 activity in left ventricle.
A, B, C, D, showing high cytoplasmic expression of bcl2 by cardiac myocytes (thick arrow), and endothelial cells (arrow head) at 30 minutes post MI in an area supplied by LAD in the left ventricle, streptavidin- biotin immunoperoxidase method.
Suhail Al-Salam (518026) +1 more
core +1 more source
Schematic illustration of ROS‐responsive TSPBA‐PVA microspheres loaded with 20‐deoxyingenol (TP/20‐DOI) for diabetic corneal wound healing: (a) fabrication and ROS‐triggered release; (b) autophagy activation and metabolic reprogramming in macrophages; (c) suppression of macrophage‐derived CXCL3/CXCL5, attenuation of neutrophil infiltration, and ...
Jiaxin Wu +20 more
wiley +1 more source
Gossypol Suppresses Growth of Temozolomide-Resistant Glioblastoma Tumor Spheres
Temozolomide is the current first-line treatment for glioblastoma patients but, because many patients are resistant to it, there is an urgent need to develop antitumor agents to treat temozolomide-resistant glioblastoma.
Hee Yeon Kim +8 more
doaj +1 more source
AUF1 binding to Bcl2 mRNA is reduced in the absence of the Bcl2 ARE-rich sequence.
A, Analysis of AUF1 protein expression in splenic B cells from Bcl2-AREflox/flox x mb1wt (flox/flox) and Bcl2-AREflox/flox x mb1cre (∆/∆) mice. Two different amounts of total cell lysates (10 and 20 μg) were loaded in SDS-PAGE gels.
Manuel D. Díaz-Muñoz (697559) +2 more
core +1 more source

